BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 30609697)

  • 1. Druggable Targets in Cyclic Nucleotide Signaling Pathways in Apicomplexan Parasites and Kinetoplastids against Disabling Protozoan Diseases in Humans.
    Kaiser A
    Int J Mol Sci; 2019 Jan; 20(1):. PubMed ID: 30609697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Small Molecule Inhibitors Targeting the Heat Shock Protein System of Human Obligate Protozoan Parasites.
    Zininga T; Shonhai A
    Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31775392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toward a Drug Against All Kinetoplastids: From LeishBox to Specific and Potent Trypanothione Reductase Inhibitors.
    Ilari A; Genovese I; Fiorillo F; Battista T; De Ionna I; Fiorillo A; Colotti G
    Mol Pharm; 2018 Aug; 15(8):3069-3078. PubMed ID: 29897765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apicomplexan phosphodiesterases in cyclic nucleotide turnover: conservation, function, and therapeutic potential.
    Moss WJ; Brusini L; Kuehnel R; Brochet M; Brown KM
    mBio; 2024 Feb; 15(2):e0305623. PubMed ID: 38132724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of potent phosphodiesterase inhibitors that demonstrate cyclic nucleotide-dependent functions in apicomplexan parasites.
    Howard BL; Harvey KL; Stewart RJ; Azevedo MF; Crabb BS; Jennings IG; Sanders PR; Manallack DT; Thompson PE; Tonkin CJ; Gilson PR
    ACS Chem Biol; 2015 Apr; 10(4):1145-54. PubMed ID: 25555060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclic-nucleotide signalling in protozoa.
    Gould MK; de Koning HP
    FEMS Microbiol Rev; 2011 May; 35(3):515-41. PubMed ID: 21223322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Everybody needs sphingolipids, right! Mining for new drug targets in protozoan sphingolipid biosynthesis.
    Mina JGM; Denny PW
    Parasitology; 2018 Feb; 145(2):134-147. PubMed ID: 28637533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional Analysis of the Expanded Phosphodiesterase Gene Family in Toxoplasma gondii Tachyzoites.
    Moss WJ; Patterson CE; Jochmans AK; Brown KM
    mSphere; 2022 Feb; 7(1):e0079321. PubMed ID: 35107337
    [No Abstract]   [Full Text] [Related]  

  • 9. Calcium-dependent signaling and kinases in apicomplexan parasites.
    Billker O; Lourido S; Sibley LD
    Cell Host Microbe; 2009 Jun; 5(6):612-22. PubMed ID: 19527888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclic nucleotide gated channels (CNGCs) in plant signalling-Current knowledge and perspectives.
    Duszyn M; Świeżawska B; Szmidt-Jaworska A; Jaworski K
    J Plant Physiol; 2019 Oct; 241():153035. PubMed ID: 31491601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extended-spectrum antiprotozoal bumped kinase inhibitors: A review.
    Van Voorhis WC; Doggett JS; Parsons M; Hulverson MA; Choi R; Arnold SLM; Riggs MW; Hemphill A; Howe DK; Mealey RH; Lau AOT; Merritt EA; Maly DJ; Fan E; Ojo KK
    Exp Parasitol; 2017 Sep; 180():71-83. PubMed ID: 28065755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug Discovery for Kinetoplastid Diseases: Future Directions.
    Rao SPS; Barrett MP; Dranoff G; Faraday CJ; Gimpelewicz CR; Hailu A; Jones CL; Kelly JM; Lazdins-Helds JK; Mäser P; Mengel J; Mottram JC; Mowbray CE; Sacks DL; Scott P; Späth GF; Tarleton RL; Spector JM; Diagana TT
    ACS Infect Dis; 2019 Feb; 5(2):152-157. PubMed ID: 30543391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. From canonical to non-canonical cyclic nucleotides as second messengers: pharmacological implications.
    Seifert R; Schneider EH; Bähre H
    Pharmacol Ther; 2015 Apr; 148():154-84. PubMed ID: 25527911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclic nucleotide signalling in malaria parasites.
    Baker DA; Drought LG; Flueck C; Nofal SD; Patel A; Penzo M; Walker EM
    Open Biol; 2017 Dec; 7(12):. PubMed ID: 29263246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Particularities of mitochondrial structure in parasitic protists (Apicomplexa and Kinetoplastida).
    de Souza W; Attias M; Rodrigues JC
    Int J Biochem Cell Biol; 2009 Oct; 41(10):2069-80. PubMed ID: 19379828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipid synthesis in protozoan parasites: a comparison between kinetoplastids and apicomplexans.
    Ramakrishnan S; Serricchio M; Striepen B; Bütikofer P
    Prog Lipid Res; 2013 Oct; 52(4):488-512. PubMed ID: 23827884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The apicoplast as a potential therapeutic target in and other apicomplexan parasites.
    Soldati D
    Parasitol Today; 1999 Jan; 15(1):5-7. PubMed ID: 10234168
    [No Abstract]   [Full Text] [Related]  

  • 18. The Role of Cyclic Nucleotides in Compensatory Hepatocyte Proliferation.
    Aladelokun O; Manautou J; Wang L
    Curr Drug Metab; 2017; 18(12):1132-1135. PubMed ID: 29090663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Infectious diseases. Overcoming neglect of kinetoplastid diseases.
    Bilbe G
    Science; 2015 May; 348(6238):974-6. PubMed ID: 26023124
    [No Abstract]   [Full Text] [Related]  

  • 20. The apicoplast as a potential therapeutic target in Toxoplasma and other apicomplexan parasites: some additional thoughts.
    Roos DS
    Parasitol Today; 1999 Jan; 15(1):41. PubMed ID: 10234180
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.